CFRA analysts increased the price target on Lonza Group (LONN:SW) (OTC: LZAGY) to CHF660 from the previous CHF610, while maintaining a "Buy" rating on the stock. The revised price target reflects an ...

Moderna is working with the Department of Health and Human Services to develop a vaccine to combat bird flu. Human to human transmission has not yet been reported.

The New York Times reports that the tentative $7.4 billion agreement with 15 states would also require those states to set aside as much as $800 million in what amounts to a legal defense fund for the ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

SAN RAFAEL, Calif., Jan. 16, 2025 /PRNewswire/ -- Imagine a world where every bite nourishes your body, every garment feels good on your skin, and every choice heals the planet. That's the ...

Moderna (NASDAQ: MRNA) was one of the hottest companies of early pandemic times, delivering a coronavirus vaccine to market in record time and quickly generating blockbuster revenue from it.

MRNA Total Operating Expenses (TTM) data by YCharts Moderna's operations burned through $2.7 billion during the 12 months that ended last September, but the company is finally getting a handle on ...

Social media users have latched onto marketing techniques that equate the completely unrelated ingredients of natural Mounjaro drink with the medication’s weight loss results, said Stephani Johnson, ...

But three norovirus vaccines are in the works, with the furthest along from Moderna, which uses the same mRNA technology as the Covid-19 vaccine. Still, the pharma giant faces a major hurdle ...

Annual infections of the virus cost the global economy around $60 billion. But three norovirus vaccines are in the works, ...